Liposomes with entrapped doxorubicin exhibit extended blood residence times.
The blood residence time of liposomes with entrapped doxorubicin is shown to be significantly longer than for identically prepared empty liposomes. Liposomal doxorubicin systems with a drug-to-lipid ratio of 0.2 (w/w) were administered at a dose of 100 mg lipid/kg. Both doxorubicin and liposomal lipid were quantified in order to assess in vivo stability and blood residence times. For empty vesicles composed of phosphatidylcholine (PC)/cholesterol (55:45, mole ratio) and sized through filters of 100 nm pore size, 15-25% of the administered lipid dose was recovered in the blood 24 h after i.v. injection. The percentage of the dose retained in the circulation at 24 h increased 2-3-fold when the liposomes contain entrapped doxorubicin. For 100 nm distearoyl PC/chol liposomal doxorubicin systems, as much as 80% of the injected dose of lipid and drug remain within the blood compartment 24 h after i.v. administration.
Bally
M B
MB
Canadian Liposome Co. Ltd, North Vancouver, Canada.
Nayar
R
R
Masin
D
D
Hope
M J
MJ
Cullis
P R
PR
Mayer
L D
LD
D000818:Animals; D002784:Cholesterol / Q000097:blood; D004317:Doxorubicin / Q000097:blood*; D004337:Drug Carriers; D004339:Drug Compounding; D005260:Female; D007700:Kinetics; D008081:Liposomes; D051379:Mice; D008811:Mice, Inbred DBA; D010713:Phosphatidylcholines / Q000097:blood
D004337:Drug Carriers; D008081:Liposomes; D010713:Phosphatidylcholines; D004317:Doxorubicin; D002784:Cholesterol